The global Sickle Cell Disease Treatment market was valued at USD 3.92 billion in 2024 and is expected to reach USD 13.21 billion by 2032
During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 16.4%, primarily driven by the rising demand of effective treat